Edward Morris

BACKGROUND: Delay to diagnosis of endometriosis is an increasing problem. As it stands, the mean delay to diagnosis time is nine years. There is limited research exploring the perceptions of healthcare professionals regarding the diagnosis …

This FIGO committee opinion paper addresses the growing body of evidence linking environmental exposures to common gynecologic and reproductive conditions across the life course. From adolescence through menopause, women are exposed to a wi…

BACKGROUND: Diagnosis of endometriosis in the United Kingdom takes on average eight years, with delay to diagnosis contributing to physical, psychological and social burden for women experiencing endometriosis. This study aimed to explore e…

(Abstracted from J Minim Invasive Gynecol 2022;29:169–176) Current treatments for women with endometriosis are largely ineffective for management of pain and other symptoms. In addition, they often affect fertility and can have undesirable …

To gain insight into the areas that impact women with endometriosis.

Medical management of endometriosis and fibroids involves manipulation of the hypothalamic-pituitary-gonadal axis to alter the balance of sex hormones thereby inhibiting disease progression and ameliorate symptoms. Unfortunately, resultant …

Abstract Acute pain generally has a well-defined onset, short duration, and defined aggravating and relieving factors and is usually associated with pathology. This chapter discusses the importance of history taking and examination for diag…

Gonadotrophin receptor hormone analogues (GnRHa) have been used in a range of sex hormone-dependent disorders. In the management of premenstrual syndrome, they can completely abolish symptoms. The success of GnRHa in the treatment of endome…

OBJECTIVE: To estimate the risk of endometrial cancer in postmenopausal women presenting with vaginal bleeding using estrogen-progestogen hormone replacement therapy (HRT) regimens and to assess if the duration of HRT use has an effect on t…

OBJECTIVES: To assess the effects of six years tibolone therapy on the genital tract in postmenopausal women against matched voluntary controls. DESIGN: Prospective, non-randomised, open label study of the efficacy of tibolone. METHODS: Sym…